TY - JOUR
T1 - Deciphering and targeting host factors to counteract SARS-CoV-2 and coronavirus infections
T2 - insights from CRISPR approaches
AU - Cui, Zhifen
AU - Wang, Hongyan
AU - Dong, Yizhou
AU - Liu, Shan Lu
AU - Wang, Qianben
N1 - Publisher Copyright:
Copyright © 2023 Cui, Wang, Dong, Liu and Wang.
PY - 2023
Y1 - 2023
N2 - Severe respiratory syndrome coronavirus 2 (SARS-CoV-2) and other coronaviruses depend on host factors for the process of viral infection and replication. A better understanding of the dynamic interplay between viral pathogens and host cells, as well as identifying of virus-host dependencies, offers valuable insights into disease mechanisms and informs the development of effective therapeutic strategies against viral infections. This review delves into the key host factors that facilitate or hinder SARS-CoV-2 infection and replication, as identified by CRISPR/Cas9-based screening platforms. Furthermore, we explore CRISPR/Cas13-based gene therapy strategies aimed at targeting these host factors to inhibit viral infection, with the ultimate goal of eradicating SARS-CoV-2 and preventing and treating related coronaviruses for future outbreaks.
AB - Severe respiratory syndrome coronavirus 2 (SARS-CoV-2) and other coronaviruses depend on host factors for the process of viral infection and replication. A better understanding of the dynamic interplay between viral pathogens and host cells, as well as identifying of virus-host dependencies, offers valuable insights into disease mechanisms and informs the development of effective therapeutic strategies against viral infections. This review delves into the key host factors that facilitate or hinder SARS-CoV-2 infection and replication, as identified by CRISPR/Cas9-based screening platforms. Furthermore, we explore CRISPR/Cas13-based gene therapy strategies aimed at targeting these host factors to inhibit viral infection, with the ultimate goal of eradicating SARS-CoV-2 and preventing and treating related coronaviruses for future outbreaks.
KW - CRISPR/Cas13-based gene therapy
KW - CRISPR/Cas9-based screening
KW - SARS-CoV-2
KW - coronavirus infections
KW - host factors
UR - https://www.scopus.com/pages/publications/85165968058
U2 - 10.3389/fgeed.2023.1231656
DO - 10.3389/fgeed.2023.1231656
M3 - Short survey
AN - SCOPUS:85165968058
SN - 2673-3439
VL - 5
JO - Frontiers in Genome Editing
JF - Frontiers in Genome Editing
M1 - 1231656
ER -